Bovine colostrum is an important source of nutritional and immunological factors that are vital for the early development and protection of the newborn. The aim of this study was to evaluate the antioxidant, mineral-binding (iron and calcium), and angiotensin-converting enzyme (ACE) inhibitory properties of the peptides generated through the enzymatic hydrolysis of bovine colostrum whey proteins. The whey proteins were hydrolyzed with pepsin at two pH values (1.3 and 2), and in a sequential hydrolysis system with pepsin and pancreatin. The hydrolysates were separated by ultrafiltration in three fractions with molecular weights of less than 10, from 10 to 30, and more than 30 kDa. The antioxidant and calcium binding activities increased with the hydrolysis and the highest values were obtained in the case of the fractions with less than 10 kDa. The fractions with molecular weights higher than 30 kDa had the best iron binding capacity. A high positive correlation (R=0.9669) was obtained between the degree of hydrolysis and the ACE inhibitory activity. El calostro bovino es una importante fuente de factores inmunológicos y nutricionales que son vitales para el desarrollo y protección de la cría. En el presente estudio se prepararon hidrolizados de proteína de suero de calostro bovino usando pepsina a dos valores de pH (1.3 y 2) y también en hidrólisis secuencial con pancreatina. Los hidrolizados se separaron por ultrafiltración para obtener 3 fracciones de distintos pesos moleculares (>30kDa, 10-30 kDa y <10kDa) para ser analizadas como fuente de péptidos con actividad antioxidante, quelante de minerales (hierro y calcio) e inhibidora de la enzima convertidora de angiotensina (ECA). Se observó un aumento en la actividad antioxidante y quelante de calcio de los hidrolizados, principalmente en las fracciones de peso molecular 30kDa. Se observó una alta correlación positiva (R=0.9669) entre el grado de hidrólisis (mEq. Leucina) y la actividad inhibidora de la ECA.
Resistance to systemic therapies in sarcomas poses a significant challenge to improving clinical outcomes. Recent research has concentrated on the tumor microenvironment’s role in sarcoma progression and treatment resistance. This microenvironment comprises a variety of cell types and signaling molecules that influence tumor behavior, including proliferation, metastasis, and resistance to therapy. Adenosine, abundant in the tumor microenvironment, has been implicated in promoting immunosuppression and chemoresistance. Targeting adenosine receptors and associated pathways offers a novel approach to enhancing immune responses against tumors, potentially improving immunotherapy outcomes in cancers, including sarcomas. Manipulating adenosine signaling also shows promise in overcoming chemotherapy resistance in these tumors. Clinical trials investigating adenosine receptor antagonists in sarcomas have fueled interest in this pathway for sarcoma treatment. Ultimately, a comprehensive understanding of the tumor and vascular microenvironments, as well as the adenosine pathway, may open new avenues for improving treatment outcomes and overcoming resistance in sarcoma. Further studies and clinical trials are crucial to validate these findings and optimize therapeutic strategies, particularly for osteosarcoma. This study provides a literature review exploring the potential role of the adenosine pathway in sarcomas.
2 November 2023 in Clinical Nutrition Open Science